A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model. 2019

Stephen R Yant, and Andrew Mulato, and Derek Hansen, and Winston C Tse, and Anita Niedziela-Majka, and Jennifer R Zhang, and George J Stepan, and Debi Jin, and Melanie H Wong, and Jill M Perreira, and Eric Singer, and Giuseppe A Papalia, and Eric Y Hu, and Jim Zheng, and Bing Lu, and Scott D Schroeder, and Kevin Chou, and Shekeba Ahmadyar, and Albert Liclican, and Helen Yu, and Nikolai Novikov, and Eric Paoli, and Daniel Gonik, and Renee R Ram, and Magdeleine Hung, and William M McDougall, and Abraham L Brass, and Wesley I Sundquist, and Tomas Cihlar, and John O Link
Gilead Sciences, Foster City, CA, USA. stephen.yant@gilead.com.

People living with HIV (PLWH) have expressed concern about the life-long burden and stigma associated with taking pills daily and can experience medication fatigue that might lead to suboptimal treatment adherence and the emergence of drug-resistant viral variants, thereby limiting future treatment options1-3. As such, there is strong interest in long-acting antiretroviral (ARV) agents that can be administered less frequently4. Herein, we report GS-CA1, a new archetypal small-molecule HIV capsid inhibitor with exceptional potency against HIV-2 and all major HIV-1 types, including viral variants resistant to the ARVs currently in clinical use. Mechanism-of-action studies indicate that GS-CA1 binds directly to the HIV-1 capsid and interferes with capsid-mediated nuclear import of viral DNA, HIV particle production and ordered capsid assembly. GS-CA1 selects in vitro for unfit GS-CA1-resistant capsid variants that remain fully susceptible to other classes of ARVs. Its high metabolic stability and low solubility enabled sustained drug release in mice following a single subcutaneous dosing. GS-CA1 showed high antiviral efficacy as a long-acting injectable monotherapy in a humanized mouse model of HIV-1 infection, outperforming long-acting rilpivirine. Collectively, these results demonstrate the potential of ultrapotent capsid inhibitors as new long-acting agents for the treatment of HIV-1 infection.

UI MeSH Term Description Entries
D007191 Indazoles A group of heterocyclic aromatic organic compounds consisting of the fusion of BENZENE and PYRAZOLES. Indazole
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D002213 Capsid The outer protein protective shell of a virus, which protects the viral nucleic acid. Capsids are composed of repeating units (capsomers or capsomeres) of CAPSID PROTEINS which when assembled together form either an icosahedral or helical shape. Procapsid,Prohead,Capsids,Procapsids,Proheads
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015498 HIV-2 An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIMIAN IMMUNODEFICIENCY VIRUS and infects only T4-lymphocytes expressing the CD4 phenotypic marker. HTLV-IV,Human T-Lymphotropic Virus Type IV,Human immunodeficiency virus 2,LAV-2,HIV-II,Human Immunodeficiency Virus Type 2,Human T Lymphotropic Virus Type IV,Immunodeficiency Virus Type 2, Human,SBL-6669
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

Stephen R Yant, and Andrew Mulato, and Derek Hansen, and Winston C Tse, and Anita Niedziela-Majka, and Jennifer R Zhang, and George J Stepan, and Debi Jin, and Melanie H Wong, and Jill M Perreira, and Eric Singer, and Giuseppe A Papalia, and Eric Y Hu, and Jim Zheng, and Bing Lu, and Scott D Schroeder, and Kevin Chou, and Shekeba Ahmadyar, and Albert Liclican, and Helen Yu, and Nikolai Novikov, and Eric Paoli, and Daniel Gonik, and Renee R Ram, and Magdeleine Hung, and William M McDougall, and Abraham L Brass, and Wesley I Sundquist, and Tomas Cihlar, and John O Link
April 2016, Antimicrobial agents and chemotherapy,
Stephen R Yant, and Andrew Mulato, and Derek Hansen, and Winston C Tse, and Anita Niedziela-Majka, and Jennifer R Zhang, and George J Stepan, and Debi Jin, and Melanie H Wong, and Jill M Perreira, and Eric Singer, and Giuseppe A Papalia, and Eric Y Hu, and Jim Zheng, and Bing Lu, and Scott D Schroeder, and Kevin Chou, and Shekeba Ahmadyar, and Albert Liclican, and Helen Yu, and Nikolai Novikov, and Eric Paoli, and Daniel Gonik, and Renee R Ram, and Magdeleine Hung, and William M McDougall, and Abraham L Brass, and Wesley I Sundquist, and Tomas Cihlar, and John O Link
February 2024, The Annals of pharmacotherapy,
Stephen R Yant, and Andrew Mulato, and Derek Hansen, and Winston C Tse, and Anita Niedziela-Majka, and Jennifer R Zhang, and George J Stepan, and Debi Jin, and Melanie H Wong, and Jill M Perreira, and Eric Singer, and Giuseppe A Papalia, and Eric Y Hu, and Jim Zheng, and Bing Lu, and Scott D Schroeder, and Kevin Chou, and Shekeba Ahmadyar, and Albert Liclican, and Helen Yu, and Nikolai Novikov, and Eric Paoli, and Daniel Gonik, and Renee R Ram, and Magdeleine Hung, and William M McDougall, and Abraham L Brass, and Wesley I Sundquist, and Tomas Cihlar, and John O Link
February 2016, Bioorganic & medicinal chemistry letters,
Stephen R Yant, and Andrew Mulato, and Derek Hansen, and Winston C Tse, and Anita Niedziela-Majka, and Jennifer R Zhang, and George J Stepan, and Debi Jin, and Melanie H Wong, and Jill M Perreira, and Eric Singer, and Giuseppe A Papalia, and Eric Y Hu, and Jim Zheng, and Bing Lu, and Scott D Schroeder, and Kevin Chou, and Shekeba Ahmadyar, and Albert Liclican, and Helen Yu, and Nikolai Novikov, and Eric Paoli, and Daniel Gonik, and Renee R Ram, and Magdeleine Hung, and William M McDougall, and Abraham L Brass, and Wesley I Sundquist, and Tomas Cihlar, and John O Link
January 2016, AIDS research and therapy,
Stephen R Yant, and Andrew Mulato, and Derek Hansen, and Winston C Tse, and Anita Niedziela-Majka, and Jennifer R Zhang, and George J Stepan, and Debi Jin, and Melanie H Wong, and Jill M Perreira, and Eric Singer, and Giuseppe A Papalia, and Eric Y Hu, and Jim Zheng, and Bing Lu, and Scott D Schroeder, and Kevin Chou, and Shekeba Ahmadyar, and Albert Liclican, and Helen Yu, and Nikolai Novikov, and Eric Paoli, and Daniel Gonik, and Renee R Ram, and Magdeleine Hung, and William M McDougall, and Abraham L Brass, and Wesley I Sundquist, and Tomas Cihlar, and John O Link
January 2023, Le infezioni in medicina,
Stephen R Yant, and Andrew Mulato, and Derek Hansen, and Winston C Tse, and Anita Niedziela-Majka, and Jennifer R Zhang, and George J Stepan, and Debi Jin, and Melanie H Wong, and Jill M Perreira, and Eric Singer, and Giuseppe A Papalia, and Eric Y Hu, and Jim Zheng, and Bing Lu, and Scott D Schroeder, and Kevin Chou, and Shekeba Ahmadyar, and Albert Liclican, and Helen Yu, and Nikolai Novikov, and Eric Paoli, and Daniel Gonik, and Renee R Ram, and Magdeleine Hung, and William M McDougall, and Abraham L Brass, and Wesley I Sundquist, and Tomas Cihlar, and John O Link
May 1999, Proceedings of the National Academy of Sciences of the United States of America,
Stephen R Yant, and Andrew Mulato, and Derek Hansen, and Winston C Tse, and Anita Niedziela-Majka, and Jennifer R Zhang, and George J Stepan, and Debi Jin, and Melanie H Wong, and Jill M Perreira, and Eric Singer, and Giuseppe A Papalia, and Eric Y Hu, and Jim Zheng, and Bing Lu, and Scott D Schroeder, and Kevin Chou, and Shekeba Ahmadyar, and Albert Liclican, and Helen Yu, and Nikolai Novikov, and Eric Paoli, and Daniel Gonik, and Renee R Ram, and Magdeleine Hung, and William M McDougall, and Abraham L Brass, and Wesley I Sundquist, and Tomas Cihlar, and John O Link
January 2015, Journal of virology,
Stephen R Yant, and Andrew Mulato, and Derek Hansen, and Winston C Tse, and Anita Niedziela-Majka, and Jennifer R Zhang, and George J Stepan, and Debi Jin, and Melanie H Wong, and Jill M Perreira, and Eric Singer, and Giuseppe A Papalia, and Eric Y Hu, and Jim Zheng, and Bing Lu, and Scott D Schroeder, and Kevin Chou, and Shekeba Ahmadyar, and Albert Liclican, and Helen Yu, and Nikolai Novikov, and Eric Paoli, and Daniel Gonik, and Renee R Ram, and Magdeleine Hung, and William M McDougall, and Abraham L Brass, and Wesley I Sundquist, and Tomas Cihlar, and John O Link
June 1988, Hypertension (Dallas, Tex. : 1979),
Stephen R Yant, and Andrew Mulato, and Derek Hansen, and Winston C Tse, and Anita Niedziela-Majka, and Jennifer R Zhang, and George J Stepan, and Debi Jin, and Melanie H Wong, and Jill M Perreira, and Eric Singer, and Giuseppe A Papalia, and Eric Y Hu, and Jim Zheng, and Bing Lu, and Scott D Schroeder, and Kevin Chou, and Shekeba Ahmadyar, and Albert Liclican, and Helen Yu, and Nikolai Novikov, and Eric Paoli, and Daniel Gonik, and Renee R Ram, and Magdeleine Hung, and William M McDougall, and Abraham L Brass, and Wesley I Sundquist, and Tomas Cihlar, and John O Link
October 2020, Science (New York, N.Y.),
Stephen R Yant, and Andrew Mulato, and Derek Hansen, and Winston C Tse, and Anita Niedziela-Majka, and Jennifer R Zhang, and George J Stepan, and Debi Jin, and Melanie H Wong, and Jill M Perreira, and Eric Singer, and Giuseppe A Papalia, and Eric Y Hu, and Jim Zheng, and Bing Lu, and Scott D Schroeder, and Kevin Chou, and Shekeba Ahmadyar, and Albert Liclican, and Helen Yu, and Nikolai Novikov, and Eric Paoli, and Daniel Gonik, and Renee R Ram, and Magdeleine Hung, and William M McDougall, and Abraham L Brass, and Wesley I Sundquist, and Tomas Cihlar, and John O Link
February 2023, Journal of medicinal chemistry,
Copied contents to your clipboard!